ACUTE LEUKEMIAS XVII
Biology and Treatment Strategies

Munich, Germany - February 24-27, 2019

International Symposium

CORPORATE SUPPORT

The support of ACUTE LEUKEMIAS XVI by the following companies is gratefully acknowledged:

 

Gold Circle Corporate Members:

Amgen GmbH
SAT II: Sunday, Feb 19, 2017
€ 20.000

 

 

Celgene GmbH
SAT V: Tuesday, Feb 21, 2017
€ 20.000

Gilead Sciences GmbH
AGIHO Grant
€ 15.000

Janssen Pharmaceutical Companies
of Johnson & Johnson in EMEA

SAT IV: Monday, Feb 20, 2017
€ 20.000

Jazz Pharmaceuticals Gemany GmbH
SAT VI: Tuesday, Feb 21, 2017
€ 20.000

Shire GmbH
SAT I: Sunday, Feb 19, 2017
€ 20.000

TEVA GmbH
SAT III: Monday, Feb 20, 2017
€ 30.000
 

TEVA has launched a new award for young scientists. Applications will be accepted until January, 15. Further details can be found at:

www.oncotomys.com

 

 

Silver Circle Corporate Members:

Novartis Pharma GmbH
MTPII: Tuesday, Feb 21, 2017
€ 10.000
Neovii Biotech GmbH
Sponsor Leukemia Clinical Research Award 2017
€ 7.500

  

 

Other Corporate Support:

Sunesis
Sponsors Poster Prizes
€ 1.000

 

 

German Research Sponsors: 

Deutsche Forschungsgemeinschaft
€ 33.000
ELN Foundation
€ 3.000

HelmholtzZentrum München

€ 4.000